SCHEMBL855973

SCHEMBL855973

CC1(CN)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8931631 0.97
SCHEMBL8608073 0.97
SCHEMBL5678718 0.88
SCHEMBL856336 0.73 GRIN2D (0.33)
SCHEMBL3671124 0.71
SCHEMBL969840 0.71
SCHEMBL855924 0.71 GRIN2D (0.35)
SCHEMBL10914880 0.69 DNM1 (0.36)
SCHEMBL19883241 0.69
SCHEMBL12997286 0.69 DNM1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820776-B2 Process for the preparation of Remimazolam and solid state forms of Remimazolam salts ASSIA CHEMICAL INDUSTRIES LTD. (IL) 2023-11-21 US claimed
US-20210277013-A1 PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SOLID STATE FORMS OF REMIMAZOLAM SALTS ASSIA CHEMICAL INDUSTRIES LTD. (IL) 2021-09-09 US claimed
WO-2018148361-A1 PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SOLID STATE FORMS OF REMIMAZOLAM SALTS WATSON LABORATORIES INC. (US) 2018-08-16 WO claimed
US-11820776-B2 Process for the preparation of Remimazolam and solid state forms of Remimazolam salts ASSIA CHEMICAL INDUSTRIES LTD. (IL) 2023-11-21 US disclosed
US-20210277013-A1 PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SOLID STATE FORMS OF REMIMAZOLAM SALTS ASSIA CHEMICAL INDUSTRIES LTD. (IL) 2021-09-09 US disclosed
US-11034697-B2 Process for the preparation of Remimazolam and solid state forms of Remimazolam salts WATSON LABORATORIES INC. (US) 2021-06-15 US disclosed
US-10428083-B2 Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-10-01 US disclosed
US-10363340-B2 Poly(oligoethylene glycol methacrylate) hydrogel compositions, and methods of use thereof MCMASTER UNIVERSITY (CA) 2019-07-30 US disclosed
EP-3274352-B1 HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR Bayer Pharma AG (DE) 2019-01-02 EP disclosed
WO-2018160855-A1 SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) PRELUDE THERAPEUTICS, INCORPORATED (US) 2018-09-07 WO disclosed
WO-2018148361-A1 PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SOLID STATE FORMS OF REMIMAZOLAM SALTS WATSON LABORATORIES INC. (US) 2018-08-16 WO disclosed
US-5114940-A Insecticides or anthelmintics from fused ring heterocycles containing amides or thioamides ROUSSEL-UCLAF (FR) 1992-05-19 US disclosed
EP-0317188-A2 Heteroaromatic enamide derivatives and their use as pesticides ROUSSEL UCLAF (FR) 1989-05-24 EP disclosed
EP-0254245-A1 Hetrazepins and processes for their preparation BOEHRINGER INGELHEIM KG (DE) 1988-01-27 EP disclosed
US-4569934-A ANTIANXIETY AGENTS AMERICAN CYANAMID COMPANY (US) 1986-02-11 US disclosed
EP-0068806-A2 Basic acyl amides of (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)methanones, processes for their production, and pharmaceutical compositions containing such compounds WARNER-LAMBERT COMPANY (US) 1983-01-05 EP disclosed
US-4150139-A MUSCLE RELAXANTS, ANALGESICS, ANTIINFLAMMATORY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1979-04-17 US disclosed
US-3992400-A 1-(α-Phenyl-o-tolyl)imidazoles THE UPJOHN COMPANY (US) 1976-11-16 US disclosed
US-3941802-A 2-(Imidazol-1-yl)benzophenones THE UPJOHN COMPANY (US) 1976-03-02 US disclosed
US-3941803-A 2-(Imidazol-1-yl)benzophenones THE UPJOHN COMPANY (US) 1976-03-02 US disclosed